betr Entertainment Limited (ASX:BBT) Announces Equity Raising and PointsBet Acquisition Proposal
betr Entertainment Limited (ASX:BBT) raises A$130 million to fund the acquisition of PointsBet, targeting over A$40 million in annual cost synergies.
Tag: Corporate Strategy & Guidance
Paradigm Biopharmaceuticals Ltd (ASX:PAR) Announces Phase 3 Trial Launch and Financial Update
Paradigm Biopharmaceuticals (ASX:PAR) announces the launch of its Phase 3 trial for knee osteoarthritis and the receipt of a $6.3 million R&D tax refund.
InteliCare Holdings Ltd (ASX:ICR) Partners with mecwacare for AI Platform Trial at Trescowthick Centre
InteliCare Holdings Ltd (ASX:ICR) partners with mecwacare to trial its AI-driven platform at Trescowthick Centre, enhancing aged care services in Victoria.
4DMedical Limited (ASX:4DX) Reports 103% Revenue Growth and Strategic Milestones
4DMedical Limited (ASX:4DX) achieves 103% YTD revenue growth and secures key strategic partnerships in Q3 FY2025.
Australian Rare Earths Limited (ASX:AR3) Announces Uranium Exploration Results
Australian Rare Earths Limited (ASX:AR3) extends uranium mineralisation at Overland Project, supporting calcrete-hosted model with assay results expected soon.
Zelira Therapeutics Ltd (ASX:ZLD) Boosts Financial Flexibility with R&D Refund and ATM Facility
Zelira Therapeutics (ASX:ZLD) enhances financial flexibility with a $1.15M R&D refund and a $1M ATM facility to support ongoing developments.
Rimfire Pacific Mining (ASX:RIM) Reports Q1 Drilling Success and Raises $3.65M
Rimfire Pacific Mining (ASX:RIM) announces successful Q1 scandium drilling at Murga and Currajong, and raises $3.65M in funding.
Odyssey Gold Limited (ASX:ODY) Commences Technical Study for Tuckanarra Project
Odyssey Gold Limited (ASX:ODY) has launched a Technical Study to evaluate mining and processing options for its Tuckanarra Gold Project.
Immutep Limited (ASX:IMM) Reports Q3 FY25 Milestones and Financial Position
Immutep Limited (ASX:IMM) announces significant clinical trial milestones and maintains a robust cash position in its Q3 FY25 report.
BrainChip Holdings Ltd (ASX:BRN) Releases Q1 2025 Activities Report
BrainChip Holdings Ltd (ASX:BRN) releases Q1 2025 report, highlighting key partnerships and a solid financial position.